Reuters logo
4 months ago
BRIEF-Botanix Pharmaceuticals receives U.S. export approval of drug for clinical studies
March 23, 2017 / 9:59 PM / 4 months ago

BRIEF-Botanix Pharmaceuticals receives U.S. export approval of drug for clinical studies

1 Min Read

March 24 (Reuters) - Botanix Pharmaceuticals Ltd

* Receives export and import approvals for clinical studies

* U.S. Drug Enforcement Agency approved export, Australian Office Of Drug Control approved import of synthetic cannabidiol for planned clinical studies Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below